News
A Comeback Fueled by Resilience Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) has been a trailblazer in the GLP-1 drug ...
Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international ...
18hon MSN
Layoffs loom at weight loss drug Wegovy's maker Novo Nordisk as slowing sales threaten job cuts
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
India Today on MSN10h
Novo Nordisk insulin and weight loss injections stolen in transit, alert issued
The regulator in its health alert letter mentioned that these stolen drugs are rDNA injectables that require strict ...
American tennis legend Serena Williams revealed taking the help of GLP-1 drugs to attain an ideal figure after struggling to ...
Novo Nordisk, the maker of the blockbuster diabetes drug Ozempic, is at the center of a brewing legal storm. Once celebrated ...
The products reported missing include insulin formulations marketed as Ryzodeg FlexTouch and Fiasp (Penfill and FlexTouch), ...
Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...
Dr Shazia Malik - a consultant obstetrician and gynaecologist for The Portland Hospital - discussed the pros and cons of ...
India Today on MSN8h
CDSCO flags stolen insulin, Wegovy: What patients must check before purchase
Certain batches of injectable medicines, including insulin and weight-loss drugs, were reported stolen in transit. Experts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback